African American Kidney Transplantation Survival

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Drugs

• Publication date

  2009-10-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/11318570-000000000-00000PMID 19791826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long‐Term Outcome of Early Steroid Withdrawal After Kidney Transplantation in African American Recipients Monitored by Surveillance Biopsy

  2008cited by this paper
• Patient Survival and Cardiovascular Risk After Kidney Transplantation: The Challenge of Diabetes

  2008cited by this paper
• Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

  2008cited by this paper
• A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow‐up

  2007cited by this paper
• Long-Term Graft Outcomes After Steroid Withdrawal in African American Kidney Transplant Recipients Receiving Sirolimus and Tacrolimus

  2007cited by this paper
• Racial differences in end-stage renal disease rates in HIV infection versus diabetes.

  2007cited by this paper
• Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy.

  2007influential reference
• Assessment of differences in HLA-A, -B, and -DRB1 allele mismatches among African-American and non-African-American recipients of deceased kidney transplants.

  2007cited by this paper
• Racial disparities in renal allograft survival: a public health issue?

  2007influential reference
• Renal function with cyclosporine C2 monitoring, enteric‐coated mycophenolate sodium and basiliximab: a 12‐month randomized trial in renal transplant recipients

  2007cited by this paper
• A systematic review of barriers in access to renal transplantation among African Americans in the United States

  2006cited by this paper
• Short‐Term Experience with Early Steroid Withdrawal in African‐American Renal Transplant Recipients

  2006influential reference
• Concentration‐controlled use of sirolimus associated with reduced exposure of cyclosporine in black recipients of primarily living renal allograft donors: 12‐month results

  2005cited by this paper
• Avoidance of Chronic Steroid Therapy in African American Kidney Transplant Recipients Monitored by Surveillance Biopsy: 1‐Year Results

  2005influential reference
• Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation.

  2005cited by this paper
• Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.

  2005cited by this paper
• Pre‐Transplant IFN‐γ ELISPOTs Are Associated with Post‐Transplant Renal Function in African American Renal Transplant Recipients

  2005cited by this paper
• Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety.

  2005cited by this paper
• A Multicenter, Prospective Study of C2-Monitored Cyclosporine Microemulsion in a U.S. Population of De Novo Renal Transplant Recipients

  2005cited by this paper
• Clinical Impact of Community‐Acquired Respiratory Viruses on Bronchiolitis Obliterans After Lung Transplant

  2005cited by this paper
• Induction Therapy with Basiliximab versus Thymoglobulin in African-American Kidney Transplant Recipients

  2005cited by this paper
• Health disparities in transplantation: focus on the complexity and challenge of renal transplantation in African Americans.

  2005cited by this paper
• Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine‐based immunosuppression and protocol biopsies

  2005influential reference
• Long‐term results of a prospective randomized trial comparing tacrolimus versus cyclosporine in African– American recipients of primary cadaver renal transplant

  2005influential reference
• Repurification: Rescue Rather Than Routine Remedy

  2005cited by this paper
• African‐American Renal Transplant Recipients Benefit from Early Corticosteroid Withdrawal Under Modern Immunosuppression

  2005influential reference
• Impact of non‐compliance on outcome after pediatric kidney transplantation: An analysis in racial subgroups

  2004influential reference
• Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed function.

  2004cited by this paper
• Observations regarding the use of sirolimus and tacrolimus in high‐risk cadaveric renal transplantation

  2004cited by this paper
• Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs.

  2004cited by this paper
• Is there an epidemic of HIV Infection in the US ESRD program?

  2004influential reference
• Race and genomics.

  2003cited by this paper
• Effect of cyclosporin pharmacokinetics on renal allograft outcome in African‐Americans

  2003cited by this paper
• The Use of Daclizumab, Tacrolimus and Mycophenolate Mofetil in African‐American and Hispanic First Renal Transplant Recipients

  2003cited by this paper
• Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus.1

  2003cited by this paper
• Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.

  2003influential reference
• Diabetes Mellitus After Kidney Transplantation in the United States

  2003cited by this paper
• Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients.

  2003cited by this paper
• Equivalent Pharmacokinetics of Mycophenolate Mofetil in African‐American and Caucasian Male and Female Stable Renal Allograft Recipients

  2003cited by this paper
• Achieving Equity in Referrals for Renal Transplant Evaluations with African-American Patients

  2003cited by this paper
• Diabetes Mellitus after Kidney Transplantation in the United States

  2003cited by this paper
• Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.

  2003cited by this paper
• Achieving equity in referrals for renal transplant evaluations with African-American patients: the role of nephrology social workers.

  2003cited by this paper
• Renal transplant recipient attitudes toward steroid use and steroid withdrawal

  2003cited by this paper
• Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirement

  2002cited by this paper
• Sirolimus-based steroid-free maintenance immunosuppression.

  2002cited by this paper
• Simulect, calcineurin inhibitor, mycophenolate mofetil, and prednisone is more effective than OKT3, calcineurin inhibitor, hycophendate mofetil, and prednisone in African American kidney recipients in reducing acute rejections and prolonging graft survival.

  2001cited by this paper
• ETHNIC DIFFERENCES IN CLINICAL RESPONSE TO CORTICOSTEROID TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION

  2001cited by this paper
• Effect of waiting time on renal transplant outcome

  2001cited by this paper
• Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era.

  2001influential reference
• Hepatitis C Virus Seropositivity at the Time of Renal Transplantation in the United States: Associated Factors and Patient Survival

  2001cited by this paper
• The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups

  2001cited by this paper
• INCREASED COSTIMULATORY RESPONSES IN AFRICAN-AMERICAN KIDNEY ALLOGRAFT RECIPIENTS

  2001influential reference
• Effect of poverty and other socioeconomic variables on renal allograft survival.

  2001cited by this paper
• Racial profiling in medical research.

  2001cited by this paper
• Sirolimus improves the two-year outcome of renal allografts in African-American patients

  2001cited by this paper
• Effect of waiting time on renal transplant outcome.

  2000cited by this paper
• Effect of mycophenolate mofetil on long-term outcomes in African american renal transplant recipients.

  2000influential reference
• RENAL TRANSPLANT PATIENT COMPLIANCE WITH FREE IMMUNOSUPPRESSIVE MEDICATIONS1

  2000cited by this paper
• The effect of Daclizumab in a high‐risk renal transplant population

  2000cited by this paper
• Late renal allograft loss: noncompliance masquerading as chronic rejection.

  1999cited by this paper
• Noncompliance in living-related donor renal transplantation: the United Network of Organ Sharing experience.

  1999cited by this paper
• Peripheral blood antigen‐presenting cells from African–Americans exhibit increased CD80 and CD86 expression

  1999influential reference
• Comparison of risk estimates for selected diseases and causes of death.

  1999cited by this paper
• Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.

  1998cited by this paper
• Barriers to cadaveric renal transplantation among blacks, women, and the poor.

  1998cited by this paper
• End-stage renal disease in specific ethnic and racial groups: risk factors and benefits of antihypertensive therapy.

  1998cited by this paper
• Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.

  1997cited by this paper
• Risk of End-stage Renal Disease in Diabetes Mellitus: A Prospective Cohort Study of Men Screened for MRFIT

  1997cited by this paper
• Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.

  1997cited by this paper
• OKT3 induction therapy and cadaveric renal transplantation in black patients.

  1997cited by this paper
• Family history of end-stage renal disease among incident dialysis patients.

  1997cited by this paper
• Are we missing an epidemic of HIV-associated nephropathy?

  1996cited by this paper
• Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors.

  1995cited by this paper
• Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.

  1992cited by this paper
• Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?

  1991cited by this paper
• Renal insufficiency in treated essential hypertension.

  1989cited by this paper

• Leukocyte immunoglobulin like receptor B3 (LILRB3) and allograft survival: can precision medicine target health disparities?

  2025cites this paper
• Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT Study): Protocol for a Randomized Controlled Trial

  2024cites this paper
• Association of Socioeconomic Position With Racial and Ethnic Disparities in Survival After Lung Transplant

  2023cites this paper
• Renal allograft performance in immigrant transplant recipients

  2020cites this paper
• Change in Mycophenolate and Tacrolimus Exposure by Transplant Vintage and Race.

  2019cites this paper
• Race/Ethnic Disparities in Cardiac Transplantation

  2019cites this paper
• Inequalities and outcomes: end stage kidney disease in ethnic minorities

  2019cites this paper
• Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients

  2018cites this paper
• Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients

  2018cites this paper
• The impact of time‐varying clinical surrogates on disparities in African‐American kidney transplant recipients – a retrospective longitudinal cohort study

  2018cites this paper
• Prolonged-Release vs Immediate-Release Tacrolimus Capsules in Black vs White Kidney Transplant Patients: A Post Hoc Analysis of Phase III Data.

  2018cites this paper
• Pharmacist‐led, technology‐assisted study to improve medication safety, cardiovascular risk factor control, and racial disparities in kidney transplant recipients

  2018cites this paper
• Improving medication safety and cardiovascular risk factor control to mitigate disparities in African-American kidney transplant recipients: Design and methods

  2017cites this paper
• Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation

  2017cites this paper
• Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients

  2017cites this paper
• Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients

  2017cites this paper
• Prevalence of CYP3A5 Genomic Variances and Their Impact on Tacrolimus Dosing Requirements among Kidney Transplant Recipients in Eastern North Carolina

  2017cites this paper
• Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients.

  2017cites this paper
• Individualizing liver transplant immunosuppression using a phenotypic personalized medicine platform

  2016cites this paper
• Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients

  2016cites this paper
• Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients

  2016cites this paper
• Twenty years of evolving trends in racial disparities for adult kidney transplant recipients.

  2016cites this paper
• African‐American Race Modifies the Influence of Tacrolimus Concentrations on Acute Rejection and Toxicity in Kidney Transplant Recipients

  2015cites this paper
• Gene Expression Profiling to Study Racial Differences after Heart Transplantation

  2015cites this paper
• Significant Racial Differences in the Key Factors Associated with Early Graft Loss in Kidney Transplant Recipients

  2014cites this paper
• Do Asian renal transplant patients need another mycophenolate mofetil dose compared with Caucasian or African American patients?

  2014cites this paper
• Long‐term outcomes in African American kidney transplant recipients under contemporary immunosuppression: a four‐yr analysis of the Mycophenolic acid Observational REnal transplant (MORE) study

  2014cites this paper
• Concomitant Proton Pump Inhibitors With Mycophenolate Mofetil and the Risk of Rejection in Kidney Transplant Recipients

  2014cites this paper
• The impact of diabetes on ethnic disparities seen in kidney transplantation.

  2013cites this paper
• Outcomes in African American Kidney Transplant Patients Receiving Tacrolimus and Mycophenolic Acid Immunosuppression

  2013cites this paper
• The Impact of Cardiovascular Disease and Risk Factor Treatment on Ethnic Disparities in Kidney Transplant

  2013cites this paper
• Racial Variation in the Development of Posttransplant Lymphoproliferative Disorders After Renal Transplantation

  2011cites this paper
• HIV infection and renal transplantation.

  2011cites this paper